Wuxi Owgels Medical Instruments Co., Ltd
| Supply Ability | 1million per week |
| Delivery Time | 3-5working days |
| Packaging Details | 25pcs per case |
| Specificity | 100% |
| Overall Agreement | 97.5% |
| Sample Type | Nasal/Throat Swab |
| Assay Incubation | 15minutes, RT |
| Format | 25T/Kit |
| N.W. | 0.3KG |
| Number of Box | 50Kits |
| Certification | CE; ISO |
| Place of Origin | Beijing |
View Detail Information
Explore similar products
Nasal Swab Covid-19 Antigen Test Kit OEM 91.08% Clinical Sensitivity
CE Approved Covid-19 Antigen Rapid Test Kit Pharyngeal Test One Step Test
Fresh Swabs Rapid Diagnostic Test Kit OEM 95.52% Sensitivity 25T/kit
SGS Covid-19 Antigen Rapid Test Kit Pharyngeal Test 25 Tests/Kit In Box
Product Specification
| Supply Ability | 1million per week | Delivery Time | 3-5working days |
| Packaging Details | 25pcs per case | Specificity | 100% |
| Overall Agreement | 97.5% | Sample Type | Nasal/Throat Swab |
| Assay Incubation | 15minutes, RT | Format | 25T/Kit |
| N.W. | 0.3KG | Number of Box | 50Kits |
| Certification | CE; ISO | Place of Origin | Beijing |
| High Light | 25T/Kit Coronavirus Test Kit ，0.3KG Coronavirus Test Kit ，Throat Swab Coronavirus Test Kit | ||
COVID-19 Antigen Rapid Test Kit Clinical Performance of Antigen Test for fresh swabs
PERFORMANCE CHARACTERCS
The assay demonstrated excellent clinical specificity 100% (95% CI: 98.12%-100%). Overall Agreement was 96.21% (93.34%-97.87%).
1. Clinical Performance of Antigen Test for fresh swabs
Using 127 fresh NP swabs which were collected freshly in Extraction Buffer in the kit to evaluate the Clinical performance of the COVID-19 Antigen Rapid Test Kit. 67 Patients who presented within 7 days of symptom onset and 60 normal persons were included in the initial primary evaluation. The Result is below:
| Sansure Covid-19 RT-PCR Assay | ||||
| Positive | Negative | Total | ||
| Kewei COVID-19 Antigen Rapid Assay | Positive | 64 | 0 | 64 |
| Negative | 3 | 60 | 63 | |
| Total | 67 | 60 | 127 | |
The assay demonstrated acceptable clinical sensitivity for fresh swab samples is 95.52% (95% CI: 87.64%-98.47%) when compared to a molecular device produced by Sansure Inc. The assay demonstrated excellent clinical specificity 100% (95% CI: 93.98%-100%). Overall Agreement was 97.64% (93.28%-99.19%).
2. Overall Clinical Performance of Antigen Test Kit
A total of above 157 positive samples and 260 negative samples were detected to evaluate the clinical performance of the COVID-19 Antigen Rapid Test Kit. The Result is below:
| Sansure Covid-19 RT-PCR Assay | ||||
| Positive | Negative | Total | ||
| Kewei COVID-19 Antigen Rapid Assay | Positive | 143 | 0 | 143 |
| Negative | 14 | 260 | 274 | |
| Total | 157 | 260 | 417 | |
The assay demonstrated acceptable total clinical sensitivity is 91.08% (95% CI: 85.59%-94.61%) when compared to a molecular device produced by Sansure Inc. The assay demonstrated excellent clinical specificity 100% (95% CI: 98.54%-100%). Overall Agreement was 96.64% (94.44%-97.99%).
4. Limit of Detection(LoD)
Limit of detection (LoD) was determined by evaluating different concentrations of heat inactivated SARS-CoV-2 virus. LoD of the SARS-CoV-2 antigen rapid kit was confirmed as 38.5 TCID50/ml.
5. High-dose Hook effect
No high dose hook effect was observed when test with up to a concentration of 6.3×105 TCID50/ml of heat inactive SARS-CoV-2 virus from Academy of Military Sciences PLA China.
6. Cross Reactivity
Many types of pneumonia are companied by fever, cough and other respiratory symptoms. In order to eliminate similar clinical symptoms of other types of pneumonia effects, pneumonia mycoplasma, influenza A, pneumococcus etc. were detected for the specific assessment. Each of the organism and viruses were tested in the absence or presence of heat inactivated SARS-CoV-2 virus(308TCID 50/ml), No cross-reactivity or interference was seen.
Company Details
Business Type:
Manufacturer
Year Established:
2001
Total Annual:
1,000,000-5,000,000
Employee Number:
100~300
Ecer Certification：
Active Member
WUXI OWGELS MEDICAL INSTRUMENTS CO., LTD. was established in 2001, is a hi-tech manufacturer of oxygen concentrator with 20 years manufacturing experience in China. Main products are medical oxygen concentrators, respiratory therapy equipements and Covid-19 Antigen Rapid test ... WUXI OWGELS MEDICAL INSTRUMENTS CO., LTD. was established in 2001, is a hi-tech manufacturer of oxygen concentrator with 20 years manufacturing experience in China. Main products are medical oxygen concentrators, respiratory therapy equipements and Covid-19 Antigen Rapid test ...
Get in touch with us
Leave a Message, we will call you back quickly!